Inactivation of SMAD4 by mutation or deletion is well described as an important and common event in the development of pancreatic and colorectal carcinoma, and less frequently is observed in cancers of numerous other localizations, including urinary bladder [16,25]. This evidence concerns the gene SMAD4 and cancer.